Danaher beats first-quarter profit estimates on strong bioprocessing demand

Life sciences firm Danaher topped first-quarter profit expectations on Tuesday, fueled by strong demand for its bioprocessing tools used in drug ​manufacturing, lifting shares 2% in premarket trading.